Ozempic goes up to 2 mg), FDA approval (Wegovy for weight management, Ozempic for diabetes), and insurance coverage patterns
Due to its high structural similarity, the peptide has been incorporated into mechanistic studies examining melanocortin receptor selectivity, agonist potency, and downstream signaling dynamics
For instance, polyamines such as spermidine exhibit protective effects, with animal studies confirming their ability to improve follicular development by enhancing ovarian antioxidant capacity and modulating autophagy (91)
The rationale for blending these two peptides stems from their non-overlapping receptor targets and complementary metabolic effects: Amylin Pathway (Cagrilintide): Targets amylin receptors in the brainstem Creates meal-specific satiety signals Slows gastric emptying through distinct mechanisms Reduces meal size and eating frequency Triple Agonist Pathway (Retatrutide): Activates GIP, GLP-1, and glucagon receptors Enhances insulin secretion and glucose metabolism Increases energy expenditure through glucagon effects Provides broader metabolic regulation When combined, these pathways could theoretically provide additive or synergistic effects on weight management and metabolic function